Hantz Financial Services Inc. trimmed its position in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 19.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,546 shares of the enterprise software provider’s stock after selling 14,748 shares during the period. Hantz Financial Services Inc.’s holdings in Oracle were worth $8,588,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Oracle by 0.8% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 14,680,278 shares of the enterprise software provider’s stock worth $2,151,395,000 after purchasing an additional 123,294 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Oracle during the 2nd quarter valued at about $1,911,930,000. Fisher Asset Management LLC lifted its holdings in shares of Oracle by 3.1% during the 3rd quarter. Fisher Asset Management LLC now owns 13,670,982 shares of the enterprise software provider’s stock valued at $1,877,026,000 after buying an additional 409,531 shares during the last quarter. Amundi grew its stake in shares of Oracle by 1.5% in the 2nd quarter. Amundi now owns 9,878,184 shares of the enterprise software provider’s stock valued at $1,447,648,000 after buying an additional 144,087 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Oracle by 1.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 8,586,492 shares of the enterprise software provider’s stock valued at $1,262,827,000 after buying an additional 147,048 shares in the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.
Oracle Price Performance
Shares of NYSE:ORCL opened at $125.31 on Monday. The company has a market cap of $378.91 billion, a price-to-earnings ratio of 19.64, a PEG ratio of 0.88 and a beta of 1.79. The business has a 50 day moving average price of $136.65 and a 200 day moving average price of $154.07. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 1.89. Oracle Corporation has a twelve month low of $109.21 and a twelve month high of $250.25.
Oracle (NYSE:ORCL – Get Free Report) last issued its quarterly earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, topping the consensus estimate of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%. The company had revenue of $19.34 billion for the quarter, compared to the consensus estimate of $19.13 billion. During the same period in the previous year, the business posted $1.47 EPS. The company’s revenue for the quarter was up 29.6% on a year-over-year basis. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Research analysts predict that Oracle Corporation will post 6.71 earnings per share for the current year.
Oracle Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, October 23rd. Investors of record on Friday, October 9th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.6%. Oracle’s payout ratio is 31.35%.
Latest Oracle News
Investors following ORCL have been watching these news items:
- Positive Sentiment: The U.S. Department of Veterans Affairs and Department of War have begun participating in Oracle Health Information Network, expanding access to health records across providers. The rollout supports Oracle Health’s reach with major public-sector customers, though the announcement did not specify financial terms. Department of Veterans Affairs and Department of War Go-Live on Oracle Health Information Network
- Positive Sentiment: Analyst support may help bolster the stock after its decline: HSBC included Oracle among stocks to buy on the dip, while Stephens upgraded the shares, according to the articles. HSBC Says Buy the Dip in These 11 Stocks Why Stephens Upgraded Oracle
- Negative Sentiment: Oracle’s large AI buildout is raising cash-flow and balance-sheet concerns. One report highlights $125 billion of debt and says the company expects free cash flow to turn positive in fiscal 2028, leaving investors focused on funding needs and the timing of returns from infrastructure spending. Oracle’s $125 Billion Debt Raises a Major AI Warning
Insider Buying and Selling
In related news, Director Stephen Rusckowski bought 25,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 29th. The shares were acquired at an average price of $139.35 per share, with a total value of $3,483,750.00. Following the completion of the transaction, the director owned 25,390 shares of the company’s stock, valued at $3,538,096.50. The trade was a 6,410.26% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Maria Smith sold 2,631 shares of the company’s stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $151.70, for a total transaction of $399,122.70. Following the transaction, the executive vice president owned 64,357 shares of the company’s stock, valued at approximately $9,762,956.90. The trade was a 3.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 36,075 shares of company stock valued at $5,342,123. 38.40% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of equities analysts recently commented on the company. Argus restated a “buy” rating and issued a $225.00 price objective on shares of Oracle in a report on Monday, September 14th. TD Cowen reiterated a “buy” rating and issued a $240.00 target price on shares of Oracle in a research note on Thursday, October 29th. Guggenheim reissued a “buy” rating on shares of Oracle in a research report on Thursday, October 29th. Rothschild & Co Redburn reduced their price objective on shares of Oracle from $155.00 to $110.00 and set a “sell” rating for the company in a research note on Monday, July 20th. Finally, HC Wainwright assumed coverage on shares of Oracle in a research note on Monday, November 2nd. They issued a “buy” rating for the company. One analyst has rated the stock with a Strong Buy rating, thirty-seven have issued a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, Oracle presently has an average rating of “Moderate Buy” and an average target price of $249.27.
Read Our Latest Stock Analysis on Oracle
About Oracle
Oracle Corporation is a technology company that develops and provides database software, cloud services, and enterprise applications. Its products help organizations manage data, run business operations, and build and deploy applications. Oracle’s offerings include Oracle Database, Oracle Cloud Infrastructure, and cloud-based applications for functions such as finance, human resources, supply chain management, and customer experience. The company also provides software support, consulting, and related services.
Featured Stories
- Five stocks we like better than Oracle
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
